This is the authors' abstract. We don't add key points for this paper.
Both vancomycin and the bacteriocin-producing probiotic altered the gut microbiota in diet-induced obese mice, but in distinct ways. Only vancomycin treatment resulted in an improvement in the metabolic abnormalities associated with obesity thereby establishing that while the gut microbiota is a realistic therapeutic target, the specificity of the antimicrobial agent employed is critical.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Murphy et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: